James K, Milne I, Merriman J, McBride W H
Br J Cancer. 1979 Feb;39(2):122-31. doi: 10.1038/bjc.1979.22.
The ability of s.c. injected tumour cells to specifically inhibit the growth of similar cells injected i.v. 2 days later has been confirmed. The capacity of tumour cells to elicit this effect varies form tumour to tumour. Furthermore, it is more readily achieved with cultured than with freshly excised tumour cells. The superior effect elicited by cultured tumour cells was not overcome by treating them with trypsin or pronase. The protection achieved was impaired in T-cell-depleted mice and mice which had been irradiated (400 rad) prior to pretreatment. In contrast, it was not affected by administration of silica, sodium aurothiomolate or cortisone acetate. The results imply that T-cell-dependent responses are involved in the protection conferred by pre-injecting tumour cells shortly before i.v. challenge.
皮下注射的肿瘤细胞能够特异性抑制两天后静脉注射的相似细胞的生长,这一点已得到证实。肿瘤细胞引发这种效应的能力因肿瘤而异。此外,培养的肿瘤细胞比新鲜切除的肿瘤细胞更容易产生这种效应。用胰蛋白酶或链霉蛋白酶处理培养的肿瘤细胞并不能消除其产生的更强效应。在T细胞耗竭的小鼠以及预处理前接受过照射(400拉德)的小鼠中,所实现的保护作用受到损害。相比之下,给予二氧化硅、硫代苹果酸金钠或醋酸可的松并不影响这种保护作用。这些结果表明,在静脉注射攻击前不久预先注射肿瘤细胞所赋予的保护作用涉及T细胞依赖性反应。